Article
Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway…
Cancer Management and Research · 2020 · Zhou X, Ji H, Ye D, Li H, Liu F, Li H, Xu J, Li Y, Xiang F
Key facts
| Title | Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer |
|---|---|
| First author | Zhou X, Ji H, Ye D, Li H, Liu F, Li H, Xu J, Li Y, Xiang F |
| Journal | Cancer Management and Research |
| Published | Jan 15, 2020 |
| DOI | 10.2147/CMAR.S228629 |
| Product codes mentioned | CEK, GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1